13D/13G Filings - Olema Pharmaceuticals Inc. (OLMA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-12-03
4:06 pm
Purchase
2020-11-2313DOlema Pharmaceuticals, Inc.
OLMA
Logos Global Management LP3,758,818
9.400%
3,758,818increase
(New Position)
Filing
History
2020-11-23
4:59 pm
Purchase
2020-11-2313GOlema Pharmaceuticals, Inc.
OLMA
Cormorant Asset Management LP3,270,544
8.140%
3,270,544increase
(New Position)
Filing
History
2020-11-20
5:23 pm
Purchase
2020-11-1913DOlema Pharmaceuticals, Inc.
OLMA
BIOTECHNOLOGY VALUE FUND LP6,661,503
16.600%
6,661,503increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2